Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05092360
Title Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab (ARTISTRY-7)
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Alkermes, Inc.
Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.